MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.
Clinical trial NCT03089645 · COMPLETED
Trial details
- NCT number
- NCT03089645
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2020-06-23
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.